Immunohistochemistry (IHC) staining of tumor tissue sections further revealed that cotreatment with ASO-circFOXK2 and tamoxifen had synergistic effects in reducing the expression of Ki67 and CCND1, as well as the abundance of p-RB (Fig. 5 I and J). The gene discussed is RB1; the disease is neoplasm.